⚒️ Ergon 全國專案數據平台 / 專案數據

Innovation Validation Call 2026

案件編號 b094d60c-30f3-4570-a592-77ff14069613
🤖 本頁數據由 Ergon AI 工作流(發現 → 真實瀏覽器採集 → 規格/AI 解析 → 附件加值)自動整理,僅供參考;申請資訊請以原始公告為準。

專案內容(AI 忠實提取,左)與原始公告頁(右)比對

Apply now to the Innovation Validation Call to accelerate the clinical validation and market launch of your digital or AI‑driven healthcare innovation!

EIT Health is calling for innovative digital and AI-powered medical technologies that are at an Innovation Maturity Level (IML) 6 and ready for clinical validation and market launch. Selected projects will be awarded funding to run pivotal clinical studies, collect real-world evidence to demonstrate safety and efficacy, apply for regulatory approval, and prepare for market commercialisation.

Who Can Apply?

  1. Consortia of at least two organisations from different countries representing at least two sides of the Knowledge Triangle (industry, research, education).
  2. A commercialising company must lead the project.
  3. Eligible solutions must be digital or AI-enabled medical devices (MDR/IVDR) at Innovation Maturity Level (IML) 6, aiming to reach IML 7 by project end.

Please refer to EIT Health’s Healthcare Innovation Cycle Framework for more information on the required Innovation Maturity Level for this call.

Funding

EIT Health will fund up to 50% of the total project budget, up to a total grant funding amount of €850 000 per project. The commercialising entity must sign a Financial Sustainability Contribution Agreement and, in the case that it is a micro or small enterprise, must receive €400 000 – €500 000 of the grant.

Funding will be awarded for up to 24 months for activities enabling clinical validation (i.e. pivotal clinical studies), regulatory submission (i.e. CE-mark application dossier), product finalisation, market readiness and commercial strategy.

Expected Outcomes

Solutions must have the potential to impact 150 000 European patients or citizens and aim to be on the market and generating at least €10 000 in revenues within 3 years after the funding period.

Information Sessions

  1. Call Information Session: 18 March 12.00 CET – Register here
  2. Open Q&A Session 1: 08 April 12.00 CET – Register here
  3. Open Q&A Session 2: 22 April 12.00 CEST – Register here

Discover more

原始公告頁(部分政府網站禁止內嵌,空白時請點右側連結) ↗ 新分頁開啟

正規化數據

類型計劃徵求 ・ 開放中
出資方EIT Health
主辦/執行EIT Health
領域標籤生醫健康資訊與AI
申請期間(未取得)
公告日期(未取得)
經費

EIT Health will fund up to 50% of the total project budget, up to a total grant funding amount of €850 000 per project. The commercialising entity must sign a Financial Sustainability Contribution Agreement and, in the case that it is a micro or small enterprise, must receive €400 000 – €500 000 of the grant.

申請資格
  1. Consortia of at least two organisations from different countries representing at least two sides of the Knowledge Triangle (industry, research, education).
  2. A commercialising company must lead the project.
  3. Eligible solutions must be digital or AI-enabled medical devices (MDR/IVDR) at Innovation Maturity Level (IML) 6, aiming to reach IML 7 by project end.
摘要

本計畫尋求已達創新成熟度第6級(IML 6)的數位或AI驅動醫療技術,資助其進行關鍵臨床研究、蒐集真實世界證據、申請規範核准及市場商業化。最高資助每項目€850,000,佔總預算50%,並要求商業化公司領導、跨國 consortia 至少兩個國家、代表產業、研究、教育兩面。

入庫時間2026-09-02 05:51 ・ 最近重訪 2026-09-02 05:51

附件(0)

此專案沒有已確認內容的附件。
Ergon 為實驗性服務・回數據平台首頁・個別案件請以原始公告為準